2010
DOI: 10.2147/jir.s12059
|View full text |Cite
|
Sign up to set email alerts
|

The effect of smoking on the symptoms and progression of multiple sclerosis: a review

Abstract: Multiple sclerosis (MS) is a chronic inflammatory neurodegenerative disorder of the central nervous system with characteristic demyelinating lesions and axonal loss. MS accounts for the most common cause of neurological disability in young adults in the Western world. The clinical manifestations and the course of MS are highly variable. The early stage of the disease is usually characterized by attacks of neurological dysfunction with complete or incomplete recovery, however, with time disability accumulates i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
15
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 155 publications
(191 reference statements)
4
15
0
Order By: Relevance
“…The documented effect of smoking and hyperlipidaemia on ‘MS-specific’ lesions supports a direct influence on MS pathology, possibly through promotion of acute inflammation 2 8–11. In line with our results, HT12 and DM13 and total VRF5 have failed to show an impact on T2 lesion volume in MS, although MS-specific lesion locations were not studied, and individual VRFs, including smoking, were not adjusted for.…”
Section: Resultssupporting
confidence: 84%
“…The documented effect of smoking and hyperlipidaemia on ‘MS-specific’ lesions supports a direct influence on MS pathology, possibly through promotion of acute inflammation 2 8–11. In line with our results, HT12 and DM13 and total VRF5 have failed to show an impact on T2 lesion volume in MS, although MS-specific lesion locations were not studied, and individual VRFs, including smoking, were not adjusted for.…”
Section: Resultssupporting
confidence: 84%
“…Through increased axonal de- With no apparent change in FA, decreased MD in the left corona radiata and superior longitudinal fasciculus of H S may be due to nicotine-related alterations in the WM. The nicotine-induced cytotoxic swelling suggested by Gazdzinski et al (22) and proinflammatory effects of cigarette smoke on tissue as shown by elevated peripheral leukocytes, and recruitment of polymorphonuclear cells, monocytes, macrophages, and increased fibrinogen may be partly responsible for cellular edema and reduced MD levels in the H S of the current study (23). Some recent studies have hypothesized on the neurotropic and promyelinating effects of smoking and have found higher FA in brain regions such as the prefrontal WM, cingulum, and corpus callosum in smokers compared with nonsmokers (9,24).…”
Section: Discussionsupporting
confidence: 48%
“…Additional deteriorating effects of the toxic contents of tobacco smoke such as cyanide, nitric oxide, and free radicals might explain the greater vulnerability of the NAWM in CIS S. The associations between thiocyanate, the main metabolite of cyanide and demyelination in the central nervous system of animals (19), and between nitric oxide and axonal degeneration, blocks in axonal conduction, especially in demyelinated axons (20) With no apparent change in FA, decreased MD in the left corona radiata and superior longitudinal fasciculus of H S may be due to nicotine-related alterations in the WM. The nicotine-induced cytotoxic swelling suggested by Gazdzinski et al (22) and proinflammatory effects of cigarette smoke on tissue as shown by elevated peripheral leukocytes, and recruitment of polymorphonuclear cells, monocytes, macrophages, and increased fibrinogen may be partly responsible for cellular edema and reduced MD levels in the H S of the current study (23). Some recent studies have hypothesized on the neurotropic and promyelinating effects of smoking and have found higher FA in brain regions such as the prefrontal WM, cingulum, and corpus callosum in smokers compared with nonsmokers (9, 24).…”
supporting
confidence: 51%
“…We demonstrated that cognitive impairment is significantly higher in MS patients that are heavy smokers. Our data are supported by other studies that have shown that smoking worsens MS symptoms 21,22. However, this study is the first to report the effects of smoking on cognition in MS patients.…”
Section: Discussionsupporting
confidence: 91%